<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Masika MM</submitter><funding>Career Development Fellowship</funding><funding>Paulo Foundation to EH, Academy of Finland</funding><funding>MM and Swedish Research Council</funding><funding>Nessling Foundation to EMK, Centre for International Mobility</funding><pagination>1286</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9230508</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(6)</volume><pubmed_abstract>Several alphaviruses, such as chikungunya (CHIKV) and Onyong-nyong (ONNV), are endemic in Kenya and often cause outbreaks in different parts of the country. We assessed the seroprevalence of alphaviruses in patients with acute febrile illness in two geographically distant areas in Kenya with no previous record of alphavirus outbreaks. Blood samples were collected from febrile patients in health facilities located in the rural Taita-Taveta County in 2016 and urban Kibera informal settlement in Nairobi in 2017 and tested for CHIKV IgG and IgM antibodies using an in-house immunofluorescence assay (IFA) and a commercial ELISA test, respectively. A subset of CHIKV IgG or IgM antibody-positive samples were further analyzed using plaque reduction neutralization tests (PRNT) for CHIKV, ONNV, and S</pubmed_abstract><journal>Viruses</journal><pubmed_title>Serological Evidence of Exposure to Onyong-Nyong and Chikungunya Viruses in Febrile Patients of Rural Taita-Taveta County and Urban Kibera Informal Settlement in Nairobi, Kenya.</pubmed_title><pmcid>PMC9230508</pmcid><funding_grant_id>TMA2017CDF-1865</funding_grant_id><funding_grant_id>318726</funding_grant_id><funding_grant_id>TM-16-1 0283</funding_grant_id><funding_grant_id>2017-05607</funding_grant_id><pubmed_authors>Uusitalo R</pubmed_authors><pubmed_authors>Huhtamo E</pubmed_authors><pubmed_authors>Gwon YD</pubmed_authors><pubmed_authors>Ogola J</pubmed_authors><pubmed_authors>Anzala O</pubmed_authors><pubmed_authors>Jaaskelainen AJ</pubmed_authors><pubmed_authors>Korhonen EM</pubmed_authors><pubmed_authors>Masika MM</pubmed_authors><pubmed_authors>Smura T</pubmed_authors><pubmed_authors>Alburkat H</pubmed_authors><pubmed_authors>Mwaengo D</pubmed_authors><pubmed_authors>Vapalahti O</pubmed_authors><pubmed_authors>Evander M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Serological Evidence of Exposure to Onyong-Nyong and Chikungunya Viruses in Febrile Patients of Rural Taita-Taveta County and Urban Kibera Informal Settlement in Nairobi, Kenya.</name><description>Several alphaviruses, such as chikungunya (CHIKV) and Onyong-nyong (ONNV), are endemic in Kenya and often cause outbreaks in different parts of the country. We assessed the seroprevalence of alphaviruses in patients with acute febrile illness in two geographically distant areas in Kenya with no previous record of alphavirus outbreaks. Blood samples were collected from febrile patients in health facilities located in the rural Taita-Taveta County in 2016 and urban Kibera informal settlement in Nairobi in 2017 and tested for CHIKV IgG and IgM antibodies using an in-house immunofluorescence assay (IFA) and a commercial ELISA test, respectively. A subset of CHIKV IgG or IgM antibody-positive samples were further analyzed using plaque reduction neutralization tests (PRNT) for CHIKV, ONNV, and S</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jun</publication><modification>2026-04-08T10:25:53.848Z</modification><creation>2025-02-19T02:57:12.275Z</creation></dates><accession>S-EPMC9230508</accession><cross_references><pubmed>35746757</pubmed><doi>10.3390/v14061286</doi></cross_references></HashMap>